A prospective one year randomized comparative clinical and MRI study of the effects of methotrexate (MTX) alone or in combination with infliximab (IFX) or intravenous (IV) pulse methylprednisolone (MP) in early rheumatoid arthritis (RA)

Durez, Patrick;Malghem, Jacques;Lauwerys, Bernard;Houssiau, Frédéric;Verschueren, P.;et.al.
(2006) Annual European Congress of Rheumatology (EULAR 2006) — Location: Amsterdam (Netherlands) (21.June.2006)

Files

No attached file found for this publication.

Details

Authors
  • Author
  • Malghem, JacquesUCLouvain
    Author
  • Lauwerys, BernardUCLouvain
    Author
  • Houssiau, FrédéricUCLouvain
    Author
  • Depresseux, GenevièveUCLouvain
    Author
  • Westhovens, ReneUCLouvain
    Author
  • Verschueren, P.
    Author
Show more
Affiliations

Citations

Durez, P., Malghem, J., Lauwerys, B., Houssiau, F., Toukap, A. N., Depresseux, G., Westhovens, R., Luyten, F. P., & Verschueren, P. (2006). A prospective one year randomized comparative clinical and MRI study of the effects of methotrexate (MTX) alone or in combination with infliximab (IFX) or intravenous (IV) pulse methylprednisolone (MP) in early rheumatoid arthritis (RA). Annals of the Rheumatic Diseases, 65, 54-55. https://hdl.handle.net/2078.5/81014 (Original work published 2006)